Sandbox Reserved 648

From Proteopedia

Revision as of 00:59, 12 November 2012 by Kasi Wetherington (Talk | contribs)
Jump to: navigation, search
This Sandbox is Reserved from 30/08/2012, through 01/02/2013 for use in the course "Proteins and Molecular Mechanisms" taught by Robert B. Rose at the North Carolina State University, Raleigh, NC USA. This reservation includes Sandbox Reserved 636 through Sandbox Reserved 685.
To get started:
  • Click the edit this page tab at the top. Save the page after each step, then edit it again.
  • Click the 3D button (when editing, above the wikitext box) to insert Jmol.
  • show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
  • Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

For more help, look at this link: http://proteopedia.org/w/Help:Getting_Started_in_Proteopedia

Contents

N-Acetylglutamate synthase

N-Acetylglutamate Synthase structure

Drag the structure with the mouse to rotate


Introduction

N-Acetylglutamate synthase (NAGS) is a mitochondrial enzyme involved in the Urea Cycle. This enzyme is most directly used in the conversion of glutamate (glutamic acid) and Coenzyme A into N-Acetylglutamate (NAG). N-Acetylglutamate synthase was first discovered as a mammalian liver enzyme but has very low rate of conservation across phyla.

In mammals, N-Acetylglutamate synthase modulates Carbamoyl phosphate synthetase I activity. Carbamoyl phosphate synthetase is the first rate limiting enzyme and well as only known enzymatic cofactor in the Urea cycle. Arginine greatly up regulates the activity of NAGS in mammals. Human NAGS is synthesized as a preprotein of 534 amino acids [1]. Between vertebral species, 197 amino acids are identical in the current NAGS alignment.

Unlike mammalian NAGS, in bacteria and fungi NAGS is inhibited by arginine.

Structure




Mechanism of action

Image:Nag-synthesis.jpg

Implications or possible application

Because of the nature of N-Acetylglutamate synthase, symptoms of NAGS deficiency present similarly to a CPSI deficiency. Both present with elevated plasma ammonia and glutamine, reduced or absent citrulline, and normal urinary orotate [2]. To tell the difference between the two, an enzyme assay with CPSI and NAG is done. Patients with NAGS deficiency will show normal CPS activity.

It is possible to treat NAGS deficiencies with a structural analog to NAG. For many patients, N-carbamylglutamate can be used to restore proper CPSI activity.

References

Morizono, Hiroki, et. al. "Molecular Genetics and Metabolism." Molecular Genetics and Metabolism. 81.April (2004): 4-11. Web. 11 Nov. 2012. <http://www.sciencedirect.com.prox.lib.ncsu.edu/science/article/pii/S1096719204000046>.

Footnotes

Personal tools